See guidance below for providers about COVID-19, including how you can get vaccinated.
For help talking with patients about the vaccine, visit COVID-19: Vaccine Communication Resources for Providers.
Become a Vaccine Provider
NYC providers who want to participate in the city's COVID-19 vaccine program will need to enroll with the Citywide Immunization Registry (CIR). They must use the CIR to electronically sign a provider agreement, place their order and report all doses administered.
Note: If you already belong to a Federal Retail Pharmacy Program network, you still need to enroll in CIR but do not need to separately enroll in the NYC COVID-19 program.
Small practices can contact NYC REACH COVID-19 Vaccine Support for assistance with ordering COVID-19 vaccines, using patient outreach tools and finding vaccination sites for patients. For more information, contact NYC REACH.
You must offer the COVID-19 vaccine to all eligible people (as per State guidance), regardless of insurance status or ability to pay.
You may not bill for the cost of the vaccine, but you are permitted to bill the recipient’s health insurance plan for an administration fee. If a recipient does not have health insurance, or if their health insurance does not cover the administration fee, you can request reimbursement for the administration of the COVID-19 vaccine through the HRSA Uninsured Program or the HRSA COVID-19 Coverage Assistance Fund.
Support Access to Vaccines
People 12 years of age and older are now eligible to be vaccinated in NYC.
The Pfizer-BioNTech vaccine is authorized for ages 12 and older. The Moderna and Johnson & Johnson/Janssen vaccines are authorized for ages 18 and older.
Vaccine Administration and Storage
Note: Translations are available for many of the documents for patients at the respective websites.
You are required to communicate information consistent with these fact sheets to patients (and provide a copy or direct the patient to the fact sheet at the manufacturer's website) before they receive the respective vaccines.
Screening now includes thrombosis with thrombocytopenia syndrome as a clinical consideration.
Sample standing orders now reference thrombosis with thrombocytopenia syndrome as it relates to the Johnson & Johnson/Janssen vaccine.
You should observe the following groups of people for 30 minutes after vaccinating:
Observe all other people for 15 minutes after injection.
If a person has a contraindication to one type of vaccine, consider consultation with an allergist-immunologist or contacting the Clinical Immunization Safety Assessment COVIDvax project before administering the other vaccine type. Consult the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States for additional guidance.
For information on reporting an adverse event in VAERS, see the Adverse Events Reporting section.
For the most up-to-date New York State guidance for retail pharmacies, visit the State’s webpage on vaccine prioritization guidance.
Long-Term Care Facilities
Mental Hygiene Providers
Clinical Considerations and Safety
Adverse Events Reporting
Certain adverse events must be reported to the Vaccine Adverse Event Reporting System (VAERS).
Best Practices and Quality Improvement
Resources including best practices to maximize efficacy and efficiency of your program.
Data on Vaccine Distribution
We encourage you to collect and report COVID-19 vaccine recipients’ race and ethnicity data to help us monitor inequities and address barriers to vaccine access and distribution. For details, see the Reporting header in the Storage and Administration section.
The following resources show data on vaccine allocation, distribution and administration.
Trainings and Webinars
Past webinar videos and slides are provided here for reference. They may not contain the most up-to-date information.
Health Alert Network and Dear Colleague Letters
Visit our archives for past communications. These are provided for reference and may not contain the most up-to-date information.